首页 | 本学科首页   官方微博 | 高级检索  
     

冠状动脉造影和PTCA术对冠心病纤溶活性的影响
引用本文:邱建,罗炎华. 冠状动脉造影和PTCA术对冠心病纤溶活性的影响[J]. 心脏杂志, 2001, 13(2): 141-143. DOI: 10.13191/j.chj.2001.02.63.qiuj.024
作者姓名:邱建  罗炎华
作者单位:广州军区广州总医院心血管内科!广东广州510010
摘    要:目的 :观察选择性冠状动脉造影 (SCA)和 PTCA对冠心病纤溶活性的影响。方法 :对接受 SCA的 45例患者和 PTCA术后 19例患者的血浆组织型纤溶酶原激活物抗原 (t- PA:Ag)、纤溶酶原激活物抑制物 (PAI1 )和纤维蛋白二聚体 (DD)含量进行动态观测。结果 :1SCA后 SCA正常组、稳定型和不稳定型心绞痛组 t- PA:Ag含量均显著升高 (P<0 .0 1) ,前者 2 4h,后者 72 h内恢复 ;活性无显著变化 ;t- PA:Ag升高程度以 SCA正常组最明显 ,显著高于稳定和不稳定型心绞痛组。 2 PTCA术后 t- PA:Ag,DD含量和 PAI1 活性均显著升高 ,PAI1 活性 3d内、t- PA :Ag 7d内恢复 ,DD含量 7d内仍高于术前。结论 :冠心病患者有 t- PA:Ag储存和释放障碍 ,SCA和 PTCA术后纤溶活性有增加趋势 ,可能与术前、术后抗血小板药物及术中、术后肝素应用有关。

关 键 词:冠状血管造影术  选择性   血管成形术  经腔  经皮冠状动脉   冠状动脉疾病   组织型纤溶酶原激活物   纤溶酶原激活物抑制物
文章编号:1009-7236(2001)02-0141-02
修稿时间:2000-03-28

Effect of fibrinolyticactivity in patients with coronary artery disease undergoing select coronary arteriographyand PTCA
QIU Jian,LUO Yan-hua. Effect of fibrinolyticactivity in patients with coronary artery disease undergoing select coronary arteriographyand PTCA[J]. Chinese Heart Journal, 2001, 13(2): 141-143. DOI: 10.13191/j.chj.2001.02.63.qiuj.024
Authors:QIU Jian  LUO Yan-hua
Affiliation:QIU Jian 1,LUO Yan hua 2
Abstract:AIM:To investigate the effects of fibrinolytic activity in patients with coronary artery disease underwent select coronary arteriography (SCA) and percutanous transluminal coronary angioplasty(PTCA). METHODS:Forty five patients underwent SCA and nineteen underwent PTCA. RESULTS:The plasma levels of tissue type plasminogen activator antigen (t PA:Ag) and corss linked fibrin degradation products (D dimer,DD) raised significantly in the groups with stable or unstable angina and the normal group after underwent SCA. At 24 h,elevated levels of t PA:Ag decreased but DD at 72 h. The elevated levels of t PA:Ag in normal group was higher than stable or unstable angina groups significantly. The activity of plasminogen activator inhibitor type 1(PAI 1) was unchanged. Underwent PTCA caused a significant increase in the plasma levels of t PA:Ag and DD and the activity of PAI 1. The elevated levels of activity of PAI 1 decreased to the pretreatment level during the period of 3 d after PTCA,but t PA:Ag during 7 d. In 7 d the levels of DD were higher than before underwent PTCA. CONCLUSION:The function of deposition and release t PA:Ag weaken in patients with coronary artery disease. The fibrinolytic activity raise after underwent SCA and PTCA,because of taken the drugs of anti platelet and heparin on pretreatment and after treated.
Keywords:coronary angiography   select  angioplasty  transluminal  percutanous coronary  coronary disease  tissue type plasminogen activator antigen  plasminogen activator inhibitor type 1
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《心脏杂志》浏览原始摘要信息
点击此处可从《心脏杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号